Don’t suffer in silence.
We hear you.
If you’re like millions of other women around the globe who are living with moderate to severe pain associated with endometriosis, you don’t have to suffer in silence. We hear you.
Dealing with symptoms that others might not understand can be frustrating, but you’re not alone. About 450 women who are living with moderate to severe pain associated with their endometriosis are expected to participate in the Edelweiss study.
What is the Edelweiss Study?
The Edelweiss study is assessing the safety and effectiveness of an investigational drug alone and in combination with hormonal add-back therapy compared to placebo in women with moderate to severe pain associated with endometriosis.
You may qualify for this study if you:
- Are 18 to 49 years old
- Have had a surgically confirmed diagnosis of endometriosis within the last 10 years
- Have endometriosis-associated pain during your period and at other times during your menstrual cycle
- Are not pregnant, breastfeeding, or planning to become pregnant
- Meet additional requirements as determined by a screening process
If you complete the study, your participation will last approximately 15 months.
To learn more about the study including the possible risks and benefits of participation, or to see if you may qualify for this study, please visit www.EndometriosisEdelweissStudy.com.
Thank you for your consideration.
Sincerely,
The Edelweiss Study Team
|
